BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu M, Zhong C, Zhang Q, Wang L, Wang L, Liu Y, Zhang X, Zhao X. pH-responsive delivery vehicle based on RGD-modified polydopamine-paclitaxel-loaded poly (3-hydroxybutyrate-co-3-hydroxyvalerate) nanoparticles for targeted therapy in hepatocellular carcinoma. J Nanobiotechnology 2021;19:39. [PMID: 33549107 DOI: 10.1186/s12951-021-00783-x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Gherasim O, Grumezescu V, Irimiciuc SA. Overview of Antimicrobial Biodegradable Polyester-Based Formulations. Int J Mol Sci 2023;24. [PMID: 36769266 DOI: 10.3390/ijms24032945] [Reference Citation Analysis]
2 Gong L, Zhao H, Liu Y, Wu H, Liu C, Chang S, Chen L, Jin M, Wang Q, Gao Z, Huang W. Research advances in peptide‒drug conjugates. Acta Pharmaceutica Sinica B 2023. [DOI: 10.1016/j.apsb.2023.02.013] [Reference Citation Analysis]
3 Bedhiafi T, Idoudi S, Alhams AA, Fernandes Q, Iqbal H, Basineni R, Uddin S, Dermime S, Merhi M, Billa N. Applications of polydopaminic nanomaterials in mucosal drug delivery. J Control Release 2023;353:842-9. [PMID: 36529384 DOI: 10.1016/j.jconrel.2022.12.037] [Reference Citation Analysis]
4 Ying N, Lin X, Xie M, Zeng D. Effect of surface ligand modification on the properties of anti-tumor nanocarrier. Colloids and Surfaces B: Biointerfaces 2022;220:112944. [DOI: 10.1016/j.colsurfb.2022.112944] [Reference Citation Analysis]
5 Wu H, Wei M, Xu Y, Li Y, Zhai X, Su P, Ma Q, Zhang H. . IJN 2022;Volume 17:3751-75. [DOI: 10.2147/ijn.s378217] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Guang Y. Ligand-modified Nanomaterials for Specific Targeting of Hepatocellular Carcinoma. Journal of Modern Nanotechnology 2022;2. [DOI: 10.53964/jmn.2022004] [Reference Citation Analysis]
7 Marcovici I, Coricovac D, Pinzaru I, Macasoi IG, Popescu R, Chioibas R, Zupko I, Dehelean CA. Melanin and Melanin-Functionalized Nanoparticles as Promising Tools in Cancer Research-A Review. Cancers (Basel) 2022;14:1838. [PMID: 35406610 DOI: 10.3390/cancers14071838] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Fan S, Lin W, Huang Y, Xia J, Xu J, Zhang J, Pi J. Advances and Potentials of Polydopamine Nanosystem in Photothermal-Based Antibacterial Infection Therapies. Front Pharmacol 2022;13:829712. [DOI: 10.3389/fphar.2022.829712] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cao L, Zhu YQ, Wu ZX, Wang GX, Cheng HW. Engineering nanotheranostic strategies for liver cancer. World J Gastrointest Oncol 2021; 13(10): 1213-1228 [PMID: 34721763 DOI: 10.4251/wjgo.v13.i10.1213] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Song Q, Chen Y, Huang Y, Dan W, Wang M, Dan N. Adhesive Capable of Underwater Adhesion and Wound Hemostasis Prepared Based on Solvent Exchange. Adv Materials Technologies 2022;7:2100852. [DOI: 10.1002/admt.202100852] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
11 Park JY, You SJ, Park K, Song YJ, Park JS, Yang DH, Kim JK, Chun HJ, Khang G. Cyclic RGDfK- and Sulfo-Cy5.5-functionalized mPEG-PCL theranostic nanosystems for hepatocellular carcinoma. Journal of Industrial and Engineering Chemistry 2021;99:204-213. [DOI: 10.1016/j.jiec.2021.04.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Li F, Liang Y, Wang M, Xu X, Zhao F, Wang X, Sun Y, Chen W. Multifunctional nanoplatforms as cascade-responsive drug-delivery carriers for effective synergistic chemo-photodynamic cancer treatment. J Nanobiotechnology 2021;19:140. [PMID: 34001157 DOI: 10.1186/s12951-021-00876-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]